CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($) $ in Thousands	Total	Common Stock Issued	Common Stock in Treasury	Paid-in Capital	Accumulated Other Comprehensive Income (Loss)	Retained Earnings
Beginning balance (in shares) at Dec. 31, 2022		25,000,000
Beginning Balance at Dec. 31, 2022	$ 268,406	$ 250	$ (368,194)	$ 326,839	$ (21,187)	$ 330,698
Beginning balance (in shares) at Dec. 31, 2022			(12,295,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(98,238)					(98,238)
Currency translation adjustment	429				429
Shares issued for employee benefit plan and compensation (in shares)		317,000
Shares issued for employee benefit plan and compensation	$ 1,293	$ 3		1,290
Purchase of treasury shares (in shares)	(165,000)		(165,000)
Purchase of treasury shares	$ (1,779)		$ (1,779)
Stock options exercised (in shares)	0
Shares Issued to directors (in shares)		29,000
Shares issued to directors	$ 0
Employee and director stock-based compensation	8,809			8,809
Ending balance (in shares) at Dec. 31, 2023		25,346,000
Ending balance at Dec. 31, 2023	178,920	$ 253	$ (369,973)	336,938	(20,758)	232,460
Ending balance (in shares) at Dec. 31, 2023			(12,460,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(24,029)					(24,029)
Currency translation adjustment	(7,592)				(7,592)
Shares issued for employee benefit plan and compensation (in shares)		338,000
Shares issued for employee benefit plan and compensation	$ 1,063	$ 4		1,059
Purchase of treasury shares (in shares)	(206,000)		(206,000)
Purchase of treasury shares	$ (1,957)		$ (1,957)
Stock options exercised (in shares)	0
Shares Issued to directors (in shares)		29,000
Shares issued to directors	$ 0
Employee and director stock-based compensation	6,700			6,700
Ending balance (in shares) at Dec. 31, 2024		25,713,000
Ending balance at Dec. 31, 2024	$ 153,105	$ 257	$ (371,930)	344,697	(28,350)	208,431
Ending balance (in shares) at Dec. 31, 2024	(12,666,443)		(12,666,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	$ (18,599)					(18,599)
Currency translation adjustment	9,235				9,235
Shares issued for employee benefit plan and compensation (in shares)		365,000
Shares issued for employee benefit plan and compensation	$ 431	$ 3		428
Purchase of treasury shares (in shares)	(872,000)		(872,000)
Purchase of treasury shares	$ (3,086)		$ (3,086)
Stock options exercised (in shares)	0
Shares Issued to directors (in shares)		68,000
Shares issued to directors	$ 0	$ 1		(1)
Employee and director stock-based compensation	5,098			5,098
Ending balance (in shares) at Dec. 31, 2025		26,146,000
Ending balance at Dec. 31, 2025	$ 146,184	$ 261	$ (375,016)	$ 350,222	$ (19,115)	$ 189,832
Ending balance (in shares) at Dec. 31, 2025	(13,537,944)		(13,538,000)